Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Accexible is a focuses on the development of technology.
Celero Systems is a life sciences company that develops an ingestible system to detect and reverse opioid overdose.
nference is a software company that creates transformative technologies and products in healthcare.
Promptly is a Real World Evidence company, collecting, integrating and analyzing data on the outcomes of care.
Neuroventis operates as a digital platform for neurology.
Chatbot coach for chronic disease management
nQ Medical is a neurotechnology company allowing Data Defined Disease Management via digital biomarkers using AI.
PharmStars has invested in 55 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
PharmStars's top investment sectors include Health Care, Biotechnology, Life Science, Medical, Commercial. The firm invests across 16 different industry categories.
Among tracked funding rounds, Nori Health received $845K in a Seed round. PharmStars's total known invested capital is $99.1M.
PharmStars's average investment size is $2.4M across its portfolio of 55 companies.
Recent PharmStars portfolio additions include Accexible, Celero Systems, nference, Promptly, Neuroventis. These companies were founded in 2020 or later.